Company Earnings Update 4 minutesRegister for Free AccessCVS Health (NYSE: CVS) 2Q19 Results: Narrows Profit and Earnings Outlook on Aetna Strength Coresight Research August 9, 2019 Executive Summary CVS Health reported 2Q19 revenues of $63.4 billion, up 35.2% year over year and ahead of the consensus estimate. Diluted EPS was $1.49, versus a loss per share of $2.52 in 2Q18. CVS closed its acquisition of Aetna in November 2018 and was the primary growth driver during the quarter, along with increased volumes and brand name drug price inflation. For FY19, CVS narrowed its adjusted EPS guidance range to $6.89-7.00 from $6.75-6.90. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Economic Sentiment Shows First Uptick in Eight Weeks; Plus, Drugstore and Pharmacy Shopping in Focus: US Consumer Survey InsightsAnalyst Corner: Is Shein’s Fashion Model a Template for Environmental Sustainability? with John MercerNRF 2025: Retail’s Big Show: Day One—Agentic AI in Focus for Nvidia; Retail Revolution for Amazon and Macy’sAnalyst Corner: US Foodservice Growth Prospects To Improve, But Tariff Uncertainty Looms—Market Outlook with Sujeet Naik
